Magazine Article | March 1, 2019

Sponsors And Providers Reaching Financial Summits

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

TIM SCOTT is an accomplished trekker. He’s conquered Kilimanjaro (19,340 feet), and recently hiked through Nepal to Everest Base Camp (17,500 feet) and Kala Pathar (18,300 feet). Careerwise, you could say he’s been attempting to climb another mountain, that of drug development and manufacturing outsourcing. And he’s doing it from both approaches to the summit.

He cofounded and lead a successful CDMO and is now doing the same at a biotech startup. When I ask him for the fundamental differences between leading organizations on the buy and sell sides of drug development and manufacturing, he starts with the financing of the two business models. “The financial pro forma driving the two businesses are so different,” he says. “It’s no wonder CDMOs and their biotech customers don’t always see eye-to-eye.” Scott is eager to share his experience to help form a mutual vision of what the summit of success looks like for drug sponsor and service provider alike.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: